Skip to main content
. 2024 Mar 26;10:17. doi: 10.1186/s40959-024-00217-1

Table 2.

Adjusted Risk of CV Mortality among β-blocker users in breast cancer

Adjusted Model Reference HR (95% CI) P-value
Metoprolol Carvedilol 0.63 (0.41–0.96) 0.03
Atenolol 0.74 (0.44–1.22) 0.24